A Dilemma for Governments: How to Pay for Million-Dollar Therapies

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Related Keywords

United States ,United Kingdom ,Argentina ,Ministry Of Health ,Al Qahirah ,Egypt ,Brazil ,Canada ,Russia ,Germany ,India ,Rio De Janeiro ,Estado Do Rio ,Ecuador ,Ireland ,South Korea ,Turkey ,Recife ,Estado De Pernambuco ,Brazilians ,Britain ,Brazilian ,American ,Adriana Ventura ,Tay Salimullah ,Thomas Crawford ,Ruth Lopert ,Azen Balbino ,Viviane Guimar ,Steven Pearson ,Rena Conti ,A Right To Health ,George Washington University ,Institute For Clinical ,Questrom School Of Business At Boston University ,Novartis ,Suhellen Oliveira Da Silva ,George Washington ,Economic Review ,Bluebird Bio ,Saharan Africa ,Questrom School ,Kid Has ,Johns Hopkins ,Vas Narasimhan ,Pharmaceuticals Prescription Drugs ,Genetic Engineering ,Babies ,Genetics And Heredity ,Children ,Disesases Health Illness Medicine ,Lawsuits ,Spinal Muscular Atrophy ,Disability , ,